pralmorelin [6420]
pralmorelin
| SMILES | C[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O |
| InChIKey | HRNLPPBUBKMZMT-RDRUQFPZSA-N |
| Sequence | AAAWFK |
| HELM | PEPTIDE1{[dA].[dNal].A.W.[dF].K.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 9 |
| Rotatable bonds | 21 |
| Log P | 1.754 |
| Molecular weight (Da) | 817.4 |
| Stereochemistry info | unspecified |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
pralmorelin
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0